Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) FCF Margin (2016 - 2025)

Historic FCF Margin for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to 37.38%.

  • Collegium Pharmaceutical's FCF Margin rose 431800.0% to 37.38% in Q3 2025 from the same period last year, while for Sep 2025 it was 38.21%, marking a year-over-year increase of 61000.0%. This contributed to the annual value of 32.2% for FY2024, which is 161900.0% down from last year.
  • Latest data reveals that Collegium Pharmaceutical reported FCF Margin of 37.38% as of Q3 2025, which was up 431800.0% from 38.5% recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's FCF Margin ranged from a high of 130.41% in Q4 2021 and a low of 30.36% during Q1 2022
  • For the 5-year period, Collegium Pharmaceutical's FCF Margin averaged around 38.25%, with its median value being 37.38% (2025).
  • In the last 5 years, Collegium Pharmaceutical's FCF Margin soared by 1027500bps in 2021 and then crashed by -799700bps in 2022.
  • Quarter analysis of 5 years shows Collegium Pharmaceutical's FCF Margin stood at 130.41% in 2021, then plummeted by -61bps to 50.44% in 2022, then fell by -3bps to 48.87% in 2023, then fell by -5bps to 46.21% in 2024, then dropped by -19bps to 37.38% in 2025.
  • Its FCF Margin stands at 37.38% for Q3 2025, versus 38.5% for Q2 2025 and 30.72% for Q1 2025.